次世代定序(NGS) 樣品製備市場規模、佔有率和成長分析（按產品/服務、工作流程、樣品類型、方法、應用、最終用戶和地區分類）－2026-2033 年產業預測

預計次世代定序(NGS) 樣品製備市場在 2024 年的價值為 21 億美元，從 2025 年的 24 億美元成長到 2033 年的 70.2 億美元，在預測期（2026-2033 年）內的複合年成長率為 14.32%。

受高通量定序技術廣泛應用的推動，全球次世代定序(NGS) 樣本製備市場正經歷顯著成長。這個關鍵流程涉及製備 DNA 或 RNA 樣本，以確保定序結果的準確性和品質。 NGS 樣本製備能夠提供關於遺傳物質和生物功能的關鍵訊息，因此備受青睞。奈米技術的創新，例如奈米磁珠、奈米流體和微流體，正在重塑樣本製備方法。這些最尖端科技透過實現更快、更精確的處理來最佳化效率，最終降低成本並縮短週轉時間。因此，NGS 樣本製備正變得越來越容易被更廣泛的研究人員和臨床醫生所接受，從而推動市場擴張。

NGS樣品製備市場促進因素

次世代定序(NGS) 樣本製備市場的發展動力源自於其在基因組研究諸多應用中的關鍵作用，包括基因表現分析、突變檢測、生物標記發現和總體基因體學。基因組學技術的進步推動了對高效能、高通量樣品製備技術（特別是針對次世代定序製備技術）的需求。這種需求的激增凸顯了開發創新方法以提高樣品製備速度和可靠性的重要性，從而支持更廣泛的基因組研究目標，並幫助科學家揭示遺傳物質的重要資訊。這些技術的持續發展將進一步促進市場成長和研究能力的提升。

次世代定序(NGS) 樣品製備市場的限制因素

次世代定序產生的大量資料為NGS樣本製備市場帶來了巨大挑戰。如此龐大的資料量需要先進的生物資訊學工具和大規模儲存解決方案，這使得基因組資料集的分析和管理變得更加複雜。應對這種複雜性需要經驗豐富的生物資訊專家、強大的基礎設施和安全的儲存系統。這些要求構成了障礙，可能會阻礙NGS樣本製備技術的廣泛高效應用，從而限制其在各種基因組研究和臨床應用中的可用性和有效性。

次世代定序（NGS）樣品製備市場趨勢

推動全球次世代定序(NGS) 樣品製備市場發展的一大趨勢是加速向自動化和高通量解決方案轉型。這一趨勢的驅動力源於對高效且擴充性的樣品處理方法的需求，以應對 NGS 工作流程中日益成長的樣品量。自動化樣品製備系統具有許多優勢，包括減少人工干預、提高重複性、提升準確性和增加樣品通量。先進的機器人技術和創新的液體處理技術的整合，簡化了包括 DNA/RNA 提取、樣品製備和靶向序列捕獲在內的各種關鍵流程，最終提高了基因組分析的效率和可靠性。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 客戶和購買標準分析
• PESTEL 分析
• 總體經濟指標
• 市場吸引力指數
• 定價分析

全球次世代定序(NGS) 樣品製備市場規模（按產品/服務分類）及複合年成長率 (2026-2033)

• 工作站/設備
• 試劑和耗材
• 服務

全球次世代定序(NGS) 樣品製備市場規模（按工作流程和複合年成長率分類）（2026-2033 年）

• DNA片段化與樣品製備
• 目標富集
• 品管

全球次世代定序(NGS) 樣品製備市場規模（按樣品類型分類）及複合年成長率 (2026-2033)

• DNA
• RNA

全球次世代定序(NGS) 樣品製備市場規模（按方法和複合年成長率分類）（2026-2033 年）

• 手動樣品製備
• 微流體樣品製備
• 基於自動化液體處理的樣品製備

全球次世代定序(NGS) 樣品製備市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 疾病診斷
  • 癌症診斷
  • 生殖健康檢查
  • 感染疾病診斷
  • 其他
• 藥物發現
• 農業和畜牧業調查
• 其他

全球次世代定序(NGS) 樣品製備市場規模（依最終用戶分類）及複合年成長率 (2026-2033)

• 醫院和診所
• 學術機構與研究中心
• 製藥和生物技術公司
• 其他

全球次世代定序(NGS) 樣品製備市場規模及複合年成長率 (2026-2033)

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Revvity Inc.
• Agilent Technologies, Inc.
• Danaher
• Becton, Dickinson and Company
• Qiagen
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• Eurofins Scientific
• BGI Group
• 10x Genomics
• Sysmex Corporation
• Psomagen
• Zymo Research Corporation
• Takara Holdings Inc
• Nanjing Novogene Bio Technology Co., Ltd.
• New England Biolabs

結論與建議

NGS Sample Preparation Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.4 Billion in 2025 to USD 7.02 Billion by 2033, growing at a CAGR of 14.32% during the forecast period (2026-2033).

The global NGS (Next-Generation Sequencing) sample preparation market is experiencing substantial growth, driven by the increasing adoption of high-throughput sequencing technologies. This essential process involves preparing DNA or RNA samples, ensuring the accuracy and quality of sequencing outcomes. The demand for NGS sample preparation is propelled by its ability to provide critical insights into genetic material and biological functions. Innovations in nanotechnology, such as nano-sized magnetic beads, nanofluidics, and microfluidics, are reshaping the landscape of sample preparation. These cutting-edge techniques optimize efficiency by enabling quicker and more precise processing, ultimately reducing costs and turnaround times. As a result, NGS sample preparation is becoming more accessible to a wider range of researchers and clinicians, fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the NGS Sample Preparation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

NGS Sample Preparation Market Segments Analysis

Global NGS Sample Preparation Market is segmented by Products & Services, Workflow, Sample Type, Method, Application, End User and Region. Based on Products & Services, the market is segmented into Workstations/Instruments, Reagents & Consumables, Services. Based on Workflow, the market is segmented into DNA Fragmentation & Library Preparation, Target Enrichment, Quality Control. Based on Sample Type, the market is segmented into DNA, RNA. Based on Method, the market is segmented into Manual Sample Preparation, Microfluidic Sample Preparation, Automated Liquid Handling-based Sample Preparation. Based on Application, the market is segmented into Disease Diagnostics (Cancer Diagnostics, Reproductive Health Diagnostics, Infectious Disease Diagnostics, Others), Drug Discovery, Agricultural & Animal Research, Others. Based on End User, the market is segmented into Hospitals & Clinics, Academic Institutes & Research Centers, Pharma & Biotech Companies, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the NGS Sample Preparation Market

The NGS sample preparation market is propelled by its essential function in a wide range of genomic research applications, including gene expression analysis, variant detection, biomarker discovery, and metagenomics. As advancements in genomics progress, there is an increasing necessity for efficient, high-throughput sample preparation techniques tailored for next-generation sequencing. This surge in demand underscores the importance of developing innovative methods that enhance the speed and reliability of sample processing, thereby supporting the broader goals of genomic research and enabling scientists to uncover critical insights into genetic material. The continuous evolution of these technologies further drives market growth and research capabilities.

Restraints in the NGS Sample Preparation Market

The NGS Sample Preparation market faces significant challenges due to the enormous data volumes generated by next-generation sequencing. This data influx demands sophisticated bioinformatics tools and extensive storage solutions, complicating the analysis and management of genomic datasets. A skilled workforce of bioinformaticians is essential for navigating these complexities, alongside the need for a robust infrastructure and secure storage systems. These requirements can create barriers that hinder the widespread adoption and efficient implementation of NGS sample preparation techniques, ultimately limiting their accessibility and effectiveness in various genomic research and clinical applications.

Market Trends of the NGS Sample Preparation Market

A notable trend shaping the global Next-Generation Sequencing (NGS) sample preparation market is the escalating shift towards automated and high-throughput solutions. This movement is propelled by the necessity for efficient, scalable approaches to manage the increasing volume of samples associated with NGS workflows. Automated sample preparation systems offer significant benefits, including reduced manual intervention, superior reproducibility, heightened accuracy, and increased sample throughput. By integrating advanced robotics and innovative liquid handling technologies, these systems streamline various critical processes, such as DNA/RNA extraction, library preparation, and target enrichment, ultimately enhancing productivity and reliability in genomic analyses.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index
• Pricing Analysis

Global NGS Sample Preparation Market Size by Products & Services & CAGR (2026-2033)

• Market Overview
• Workstations/Instruments
• Reagents & Consumables
• Services

Global NGS Sample Preparation Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• DNA Fragmentation & Library Preparation
• Target Enrichment
• Quality Control

Global NGS Sample Preparation Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• DNA
• RNA

Global NGS Sample Preparation Market Size by Method & CAGR (2026-2033)

• Market Overview
• Manual Sample Preparation
• Microfluidic Sample Preparation
• Automated Liquid Handling-based Sample Preparation

Global NGS Sample Preparation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Others
• Drug Discovery
• Agricultural & Animal Research
• Others

Global NGS Sample Preparation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Academic Institutes & Research Centers
• Pharma & Biotech Companies
• Others

Global NGS Sample Preparation Market Size & CAGR (2026-2033)

• North America (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • US
  • Canada
• Europe (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanjing Novogene Bio Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation